UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 85

Sortiert nach

Field validation of a Leishmania (Leishmania) mexicana exo-antigens ELISA for diagnosing tegumentary leishmaniasis in regions of Leishmania (Viannia) predominance

The Brazilian journal of infectious diseases, 2015-05, Vol.19 (3), p.302-307

2015

Volltextzugriff (PDF)

Comparison of cardiotoxicity between N-methyl-glucamine and miltefosine in the treatment of American cutaneous leishmaniasis

Anais brasileiros de dermatología, 2021-07, Vol.96 (4), p.502-504

2021

Volltextzugriff (PDF)

Leprosy detection rate in patients under immunosuppression for the treatment of dermatological, rheumatological, and gastroenterological diseases: a systematic review of the literature and meta-analysis

BMC infectious diseases, 2021-04, Vol.21 (1), p.347-9, Article 347

2021

Volltextzugriff (PDF)

Meglumine antimoniate was associated with a higher cure rate than liposomal amphotericin B in the treatment of American tegumentary leishmaniasis: A retrospective cohort study from a Leishmania braziliensis-endemic area

Frontiers in cellular and infection microbiology, 2022-09, Vol.12, p.993338-993338

2022

Volltextzugriff (PDF)

Successful treatment of diffuse cutaneous leishmaniasis caused by Leishmania amazonensis

Anais brasileiros de dermatología, 2021-09, Vol.96 (5), p.602-604

2021

Volltextzugriff (PDF)

The Presence of Leishmania braziliensis DNA in the Nasal Mucosa of Cutaneous Leishmaniasis Patients and the Search for Possible Clinical and Immunological Patterns of Disease Progression: A Cross Sectional Study

Frontiers in cellular and infection microbiology, 2021-10, Vol.11, p.744163-744163

2021

Volltextzugriff (PDF)

A Pilot Randomized Clinical Trial: Oral Miltefosine and Pentavalent Antimonials Associated With Pentoxifylline for the Treatment of American Tegumentary Leishmaniasis

Frontiers in cellular and infection microbiology, 2021-07, Vol.11, p.700323-700323

2021

Volltextzugriff (PDF)

PD-L1 May Mediate T-Cell Exhaustion in a Case of Early Diffuse Leishmaniasis Caused by Leishmania (L.) amazonensis

Frontiers in immunology, 2018-05, Vol.9, p.1021-1021

2018

Volltextzugriff (PDF)

A retrospective cohort study of the effectiveness and adverse events of intralesional pentavalent antimonials in the treatment of cutaneous leishmaniasis

International journal for parasitology -- drugs and drug resistance, 2020-12, Vol.14, p.257-263

2020

Volltextzugriff (PDF)

Complementary exams in the diagnosis of American tegumentary leishmaniasis

Anais brasileiros de dermatología, 2014-09, Vol.89 (5), p.701-709

2014

Volltextzugriff (PDF)

The accuracy of the Montenegro skin test for leishmaniasis in PCR-negative patients

Revista da Sociedade Brasileira de Medicina Tropical, 2020-01, Vol.53, p.e20190433-e20190433

2020

Volltextzugriff (PDF)

A comprehensive systematic review of leishmaniasis in patients undergoing drug-induced immunosuppression for the treatment of dermatological, rheumatological and gastroenterological diseases

Revista do Instituto de Medicina Tropical de São Paulo, 2020-01, Vol.62, p.e28-9

2020

Volltextzugriff (PDF)

American cutaneous leishmaniasis triggered by electrocoagulation

Revista da Sociedade Brasileira de Medicina Tropical, 2018-01, Vol.51 (1), p.108-110

2018

Volltextzugriff (PDF)

A randomized, open-label clinical trial comparing the long-term effects of miltefosine and meglumine antimoniate for mucosal leishmaniasis

Revista da Sociedade Brasileira de Medicina Tropical, 2019-01, Vol.52, p.e20180292-e20180292

2019

Volltextzugriff (PDF)

The interference of polypharmacy and the importance of clinical pharmacy advice in the treatment of leprosy: a case-control study

Revista da Sociedade Brasileira de Medicina Tropical, 2020-01, Vol.53, p.e20200114-e20200114

2020

Volltextzugriff (PDF)

Accuracy of mucocutaneous leishmaniasis diagnosis using polymerase chain reaction: systematic literature review and meta-analysis

Memórias do Instituto Oswaldo Cruz, 2015-04, Vol.110 (2), p.157-165

2015

Volltextzugriff (PDF)

Field Validation of SYBR Green- and TaqMan-Based Real-Time PCR Using Biopsy and Swab Samples To Diagnose American Tegumentary Leishmaniasis in an Area Where Leishmania (Viannia) braziliensis Is Endemic

Journal of clinical microbiology, 2017-02, Vol.55 (2), p.526-534

2017

Volltextzugriff (PDF)

Miltefosine enhances phagocytosis but decreases nitric oxide production by peritoneal macrophages of C57BL/6 mice

International immunopharmacology, 2012-05, Vol.13 (1), p.114-119

2012

Volltextzugriff (PDF)

Effectiveness of miltefosine-pentoxifylline compared to miltefosine in the treatment of cutaneous leishmaniasis in C57Bl/6 mice

Revista da Sociedade Brasileira de Medicina Tropical, 2014-07, Vol.47 (4), p.517-520

2014

Volltextzugriff (PDF)

No evidence for cardiotoxicity of miltefosine – Reply

Anais brasileiros de dermatología, 2022-07, Vol.97 (4), p.549-550

2022

Volltextzugriff (PDF)

Lutzomyia whitmani is the main vector of American Cutaneous Leishmaniasis in the Brazilian Federal District and the most prevalent species in residential areas of the Administrative Region of Sobradinho

Anais brasileiros de dermatología, 2014-04, Vol.89 (2), p.372-374

2014

Volltextzugriff (PDF)

Study of the efficacy of N-methyl glucamine antimoniate (SbV) associated with photodynamic therapy using liposomal chloroaluminium phthalocyanine in the treatment of cutaneous leishmaniasis caused by Leishmania (L.) amazonensis in C57BL6 mice

Photodiagnosis and photodynamic therapy, 2019-06, Vol.26, p.261-269

2019

Volltextzugriff (PDF)

Leishmanicidal activity of amphotericin B encapsulated in PLGA–DMSA nanoparticles to treat cutaneous leishmaniasis in C57BL/6 mice

Experimental parasitology, 2013-10, Vol.135 (2), p.217-222

2013

Volltextzugriff (PDF)

Evaluation of the efficacy of systemic miltefosine associated with photodynamic therapy with liposomal chloroaluminium phthalocyanine in the treatment of cutaneous leishmaniasis caused by Leishmania (L.) amazonensis in C57BL/6 mice

Photodiagnosis and photodynamic therapy, 2016-03, Vol.13, p.282-290

2016

Volltextzugriff (PDF)

Meglumine antimonate treatment enhances phagocytosis and TNF-α production by monocytes in human cutaneous leishmaniasis

Transactions of the Royal Society of Tropical Medicine and Hygiene, 2012-10, Vol.106 (10), p.596-603

2012

Volltextzugriff (PDF)

1 – 25 von 85

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(83)
Mit Volltextzugriff
(85)

Publikationsform

Artikel
(83)
Berichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(35)
Science & Technology
(35)
Leishmaniasis
(20)
Tropical Medicine
(20)
Humans
(15)
Animals
(14)
Parasitology
(14)
Cutaneous Leishmaniasis
(13)
Dermatology
(13)
Female
(13)
Male
(13)
Leishmania Braziliensis
(11)
Leishmaniasis, Cutaneous - Drug Therapy
(11)
Adult
(9)
Mice, Inbred C57bl
(8)
Mice
(7)
Miltefosine
(7)
Antiprotozoal Agents - Administration & Dosage
(6)
Diagnosis
(6)
Infectious Diseases
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Field validation of a Leishmania (Leishmania) mexicana exo-antigens ELISA for diagnosing tegumentary leishmaniasis in regions of Leishmania (Viannia) predominance

Comparison of cardiotoxicity between N-methyl-glucamine and miltefosine in the treatment of American cutaneous leishmaniasis

Leprosy detection rate in patients under immunosuppression for the treatment of dermatological, rheumatological, and gastroenterological diseases: a systematic review of the literature and meta-analysis

Meglumine antimoniate was associated with a higher cure rate than liposomal amphotericin B in the treatment of American tegumentary leishmaniasis: A retrospective cohort study from a Leishmania braziliensis-endemic area

Successful treatment of diffuse cutaneous leishmaniasis caused by Leishmania amazonensis

The Presence of Leishmania braziliensis DNA in the Nasal Mucosa of Cutaneous Leishmaniasis Patients and the Search for Possible Clinical and Immunological Patterns of Disease Progression: A Cross Sectional Study

A Pilot Randomized Clinical Trial: Oral Miltefosine and Pentavalent Antimonials Associated With Pentoxifylline for the Treatment of American Tegumentary Leishmaniasis

PD-L1 May Mediate T-Cell Exhaustion in a Case of Early Diffuse Leishmaniasis Caused by Leishmania (L.) amazonensis

A retrospective cohort study of the effectiveness and adverse events of intralesional pentavalent antimonials in the treatment of cutaneous leishmaniasis

Complementary exams in the diagnosis of American tegumentary leishmaniasis

The accuracy of the Montenegro skin test for leishmaniasis in PCR-negative patients

A comprehensive systematic review of leishmaniasis in patients undergoing drug-induced immunosuppression for the treatment of dermatological, rheumatological and gastroenterological diseases

American cutaneous leishmaniasis triggered by electrocoagulation

A randomized, open-label clinical trial comparing the long-term effects of miltefosine and meglumine antimoniate for mucosal leishmaniasis

The interference of polypharmacy and the importance of clinical pharmacy advice in the treatment of leprosy: a case-control study

Accuracy of mucocutaneous leishmaniasis diagnosis using polymerase chain reaction: systematic literature review and meta-analysis

Field Validation of SYBR Green- and TaqMan-Based Real-Time PCR Using Biopsy and Swab Samples To Diagnose American Tegumentary Leishmaniasis in an Area Where Leishmania (Viannia) braziliensis Is Endemic

Miltefosine enhances phagocytosis but decreases nitric oxide production by peritoneal macrophages of C57BL/6 mice

Effectiveness of miltefosine-pentoxifylline compared to miltefosine in the treatment of cutaneous leishmaniasis in C57Bl/6 mice

No evidence for cardiotoxicity of miltefosine – Reply

Lutzomyia whitmani is the main vector of American Cutaneous Leishmaniasis in the Brazilian Federal District and the most prevalent species in residential areas of the Administrative Region of Sobradinho

Study of the efficacy of N-methyl glucamine antimoniate (SbV) associated with photodynamic therapy using liposomal chloroaluminium phthalocyanine in the treatment of cutaneous leishmaniasis caused by Leishmania (L.) amazonensis in C57BL6 mice

Leishmanicidal activity of amphotericin B encapsulated in PLGA–DMSA nanoparticles to treat cutaneous leishmaniasis in C57BL/6 mice

Evaluation of the efficacy of systemic miltefosine associated with photodynamic therapy with liposomal chloroaluminium phthalocyanine in the treatment of cutaneous leishmaniasis caused by Leishmania (L.) amazonensis in C57BL/6 mice

Meglumine antimonate treatment enhances phagocytosis and TNF-α production by monocytes in human cutaneous leishmaniasis

Suchergebnisse filtern